Facial Soft Tissue Augmentation using Autologous Fat Mixed with Stromal Vascular Fraction

Background Autologous fat grafting evolved over the twentieth century to become a quick, safe, and reliable method for restoring volume. However, autologous fat grafts have some problems including uncertain viability of the grafted fat and a low rate of graft survival. To overcome the problems associated with autologous fat grafts, we used uncultured adipose tissue-derived stromal cell (stromal vascular fraction, SVF) assisted autologous fat grafting. Thus, the purpose of this study was to evaluate the effect of SVF in a clinical trial.

Methods SVF cells were freshly isolated from half of the aspirated fat and were used in combination with the other half of the aspirated fat during the procedure. Between March 2007 and February 2008, a total of 9 SVF-assisted fat grafts were performed in 9 patients. The patients were followed for 12 weeks after treatment. Data collected at each follow-up visit included clinical examination of the graft site(s), photographs for historical comparison, and information from a patient questionnaire that measured the outcomes from the patient perspective. The photographs were evaluated by medical professionals.

Results Scores of the left facial area grafted with adipose tissue mixed with SVF cells were significantly higher compared with those of the right facial area grafted with adipose tissue without SVF cells. There was no significant adverse effect.

Conclusions The subjective patient satisfaction survey and surgeon survey showed that SVF-assisted fat grafting was a surgical procedure with superior results.

Keywords

Cell transplants - Tissue grafts - Mesenchymal stem cells - Adipose tissue

Publication History

Received: 25 May 2012

Accepted: 03 August 2012

Article published online:
01 May 2022

• REFERENCES

• 1 Illouz YG. The fat cell "graft": a new technique to fill depressions. Plast Reconstr Surg 1986; 78: 122-123
• 2 Kim SB, Kim DW, Yoon ES. Facial fat injection: long-term follow-up results. J Korean Soc Aesthetic Plast Surg 2010; 16: 35-40
• 3 Zuk PA, Zhu M, Mizuno H. et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228
• 4 Dhar S, Yoon ES, Kachgal S. et al. Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Eng 2007; 13: 2625-2632
• 5 Yoon E, Dhar S, Chun DE. et al. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007; 13: 619-627
• 6 Jeong T, Ji YH, Kim DW. et al. Treatment of phalageal bone defect using autologous stromal vascular fraction from lipoaspirated tissue. J Korean Soc Plast Reconstr Surg 2011; 38: 438-444
• 7 Poloni A, Maurizi G, Leoni P. et al. Human dedifferentiated adipocytes show similar properties to bone marrow-derived mesenchymal stem cells. Stem Cells 2012; 30: 965-974
• 8 Coleman SR. Hand rejuvenation with structural fat grafting. Plast Reconstr Surg 2002; 110: 1731-1744
• 9 Tabit CJ, Slack GC, Fan K. et al. Fat grafting versus adipose-derived stem cell therapy: distinguishing indications, techniques, and outcomes. Aesthetic Plast Surg 2012; 36: 704-713
• 10 Ersek RA, Chang P, Salisbury MA. Lipo layering of autologous fat: an improved technique with promising results. Plast Reconstr Surg 1998; 101: 820-826
• 11 Leblanc AJ, Touroo JS, Hoying JB. et al. Adipose stromal vascular fraction cell construct sustains coronary microvascular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2012; 302: H973-H982
• 12 Lendeckel S, Jodicke A, Christophis P. et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32: 370-373